TLSATiziana Life Sciences Ltd

Nasdaq tizianalifesciences.com


$ 0.62 $ -0.01 (-1.78 %)    

Monday, 13-May-2024 12:54:43 EDT
QQQ $ 443.30 $ -1.48 (-0.33 %)
DIA $ 394.45 $ -0.64 (-0.16 %)
SPY $ 521.08 $ -1.10 (-0.21 %)
TLT $ 90.60 $ -0.01 (-0.02 %)
GLD $ 217.66 $ -0.18 (-0.08 %)
$ 0.6116
$ 0.62
$ 0.00 x 0
$ 0.00 x 0
$ 0.62 - $ 0.62
$ 0.41 - $ 1.27
95,628
na
63.05M
$ 0.86
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 tiziana-life-sciences-reports-3-month-neuroimaging-scores-in-multiple-sclerosis-patients-receiving-intranasal-foralumab-a-primary-endpoint-with-clinical-measures-of-edss-disability-and-mfis-fatigue-is-currently-underway

Tiziana Life Sciences, Ltd. (NASDAQ:TLSA) ("Tiziana" or the "Company"), a biotechnology company developing brea...

 tiziana-life-sciences-announces-fda-allowance-for-additional-patients-to-be-enrolled-in-intranasal-foralumab-multiple-sclerosis-expanded-access-program

Program to expand from 10 patients to a total of 30 patients.

 tiziana-life-sciences-announces-additional-clinical-improvements-among-multiple-sclerosis-patients-in-its-expanded-access-program

Tiziana Life Sciences, Ltd. (NASDAQ:TLSA) ("Tiziana" or the "Company"), a biotechnology company developing brea...

 tiziana-life-sciences-announces-updated-clinical-and-pet-scan-findings-for-intranasal-foralumab-in-two-new-multiple-sclerosis-patients

Tiziana Life Sciences Ltd. (NASDAQ:TLSA) ("Tiziana" or the "Company"), a biotechnology company developing break...

 tesla-shares-hardly-damaged-despite-recall-full-self-driving-is-elon-musks-holy-grail-analyst-says

Tesla shares fell only slightly. And auto recalls are nothing new. Recall how, in 1981, Ford issued a recall on 21 million vehi...

 dont-get-caught-in-equity-rally-hype-lessons-from-2023-to-remember-in-2024

After a volatile 2023, equity markets appear to be rallying into 2024. Can they keep it up?

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION